In recent years, the number of people suffering from obesity in the world is increasing, and there are many diseases such as liver and cardiovascular problems associated with obesity.

Since Novo Nordisk's weight loss drug Sommarutide injection Wegovy was approved by the FDA for obesity in 2021, GLP-1R has received widespread attention and is a blockbuster star drug for weight loss and hypoglycemic effects in recent years! Among them, the oral sommarutide is a new generation version after the injection type.

How sommarlutide was born:

In December 2017, the U.S. Food and Drug Administration (FDA) approved Simeglotide injection for the control of blood sugar in adults with type 2 diabetes.

In January 2020, it was approved by the FDA to reduce the risk of major cardiovascular adverse events in adults with type 2 diabetes with cardiovascular disease.

In December 2020, Novo Nordisk submitted a marketing application to the FDA for semaglutide 2.4mg once weekly subcutaneous injection for weight loss.

In April 2021, it was approved by the National Food and Drug Administration (NMPA) for the treatment of adult type 2 diabetes and to reduce the risk of cardiovascular adverse events in T2DM patients with cardiovascular disease.

Approved by the FDA in June 2021 for the treatment of obesity, Simeaglutide (Wegovy) injection is approved for use in obese adults with a BMI of 30 kg/m2 or in overweight adults with at least one weight-related disease (such as hypertension, type 2 diabetes or dyslipidemia) (BMI of 27 kg/m2). Studies have shown that obese patients treated with semaglutide lost an average of 17-18% of their body weight over 68 weeks.

In January 2023, the FDA approved a new indication for Wegovy (semaglutide injection, Semaglutide) : Used as an adjunctive to a low-calorie diet and increased physical activity for chronic weight management in pediatric patients 12 years and older with an initial body mass index (BMI) of 95% or more for age and sex (obesity). It is one of the few drugs in the world that has been officially approved by the FDA for the treatment of obesity.

Where to buy Semaglutide? Shaanxi zebrago Industrial

【 Go Back 】 | 【 Print 】